Open AccessDevelopment of clinically significant systolic hypertension for the COX-2 selective inhibitor valdecoxib is similar to placebo and conventional NSAIDs in hypertensive patients with chronic arthritis
Author(s) -
W WHITE,
A WHELTON,
Shihui Pan,
R. Cheung
Publication year - 2005
Publication title -
american journal of hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.009
H-Index - 136
eISSN - 1941-7225
pISSN - 0895-7061
DOI - 10.1016/j.amjhyper.2005.03.270
Subject(s) - valdecoxib , medicine , naproxen , rofecoxib , celecoxib , placebo , arthritis , anesthesia , osteoarthritis , etoricoxib , diclofenac , pharmacology , gastroenterology , cyclooxygenase , pathology , biochemistry , chemistry , alternative medicine , enzyme
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom